scholarly article | Q13442814 |
P50 | author | Raymond W. Tennant | Q111734405 |
P2093 | author name string | Jie Liu | |
Richard S Paules | |||
Jun Shen | |||
Michael P Waalkes | |||
B Alex Merrick | |||
Bhalchandra A Diwan | |||
Charles J Tucker | |||
Yaxiong Xie | |||
Sherry F Grissom | |||
Danica M K Ducharme | |||
P2860 | cites work | Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation | Q23923186 |
Structural determinants of the BRCA1 : estrogen receptor interaction | Q24292926 | ||
Pathology related to chronic arsenic exposure | Q24812702 | ||
Biokinetics and subchronic toxic effects of oral arsenite, arsenate, monomethylarsonic acid, and dimethylarsinic acid in v-Ha-ras transgenic (Tg.AC) mice | Q24813432 | ||
Chronic arsenic poisoning from burning high-arsenic-containing coal in Guizhou, China | Q24815568 | ||
Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors | Q26341280 | ||
Sodium arsenite-induced dysregulation of proteins involved in proliferative signaling | Q28376773 | ||
Subchronic exposure to arsenic through drinking water alters expression of cancer-related genes in rat liver | Q28574362 | ||
Overall evaluations of carcinogenicity: an updating of IARC Monographs volumes 1 to 42 | Q29617985 | ||
Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643. | Q31141170 | ||
Hepatic damage caused by chronic arsenic toxicity in experimental animals | Q31423066 | ||
Genetic events associated with arsenic-induced malignant transformation: applications of cDNA microarray technology | Q32163220 | ||
c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry | Q33775134 | ||
Interaction between genetic susceptibility and early-life environmental exposure determines tumor-suppressor-gene penetrance | Q33854006 | ||
Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasms in experimental animal models | Q33942505 | ||
Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites | Q33943279 | ||
Arsenite is a cocarcinogen with solar ultraviolet radiation for mouse skin: an animal model for arsenic carcinogenesis. | Q34093044 | ||
Transcription factor Nrf2 activation by inorganic arsenic in cultured keratinocytes: involvement of hydrogen peroxide | Q34271126 | ||
Role of abnormal methionine metabolism in alcoholic liver injury | Q34774377 | ||
Risk of internal cancers from arsenic in drinking water | Q35135577 | ||
The role of the IGF axis in hepatocarcinogenesis | Q35622480 | ||
Does arsenic exposure increase the risk for liver cancer? | Q35889155 | ||
Expressions of cysteine-rich61, connective tissue growth factor and Nov genes in hepatocellular carcinoma and their clinical significance | Q36076333 | ||
Frequent trefoil factor 3 (TFF3) overexpression and promoter hypomethylation in mouse and human hepatocellular carcinomas | Q36539398 | ||
Overexpression of glutathione S-transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic. | Q38298986 | ||
Stress-related gene expression in mice treated with inorganic arsenicals | Q38300842 | ||
Toxicogenomic analysis of aberrant gene expression in liver tumors and nontumorous livers of adult mice exposed in utero to inorganic arsenic | Q38346625 | ||
Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation | Q40394083 | ||
Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1). Evidence that a tri-glutathione conjugate is required | Q40552078 | ||
Transformation by inorganic arsenic compounds of normal Syrian hamster embryo cells into a neoplastic state in which they become anchorage-independent and cause tumors in newborn hamsters | Q40718654 | ||
Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation | Q40780343 | ||
Epidemiological characteristics and risk factors of hepatocellular carcinoma | Q41667321 | ||
Metallothionein-I/II null mice are more sensitive than wild-type mice to the hepatotoxic and nephrotoxic effects of chronic oral or injected inorganic arsenicals | Q43503559 | ||
Application of cDNA microarray to the study of arsenic-induced liver diseases in the population of Guizhou, China | Q43514284 | ||
Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma | Q43632451 | ||
Arsenic induced changes in growth development and apoptosis in neonatal and adult brain cells in vivo and in tissue culture | Q43899315 | ||
Sodium arsenite administration via drinking water increases genome-wide and Ha-ras DNA hypomethylation in methyl-deficient C57BL/6J mice | Q43997212 | ||
Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors | Q44085015 | ||
Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice | Q44313185 | ||
Induction of tumors of the liver, lung, ovary and adrenal in adult mice after brief maternal gestational exposure to inorganic arsenic: promotional effects of postnatal phorbol ester exposure on hepatic and pulmonary, but not dermal cancers | Q44599839 | ||
Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero | Q44802943 | ||
Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis | Q44836543 | ||
Disregulation of E-cadherin in transgenic mouse models of liver cancer | Q47281445 | ||
Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice | Q49230994 | ||
Down-regulation of metallothionein expression in human and murine hepatocellular tumors: association with the tumor-necrotizing and antineoplastic effects of cadmium in mice. | Q53454946 | ||
Cancer burden from arsenic in drinking water in Bangladesh | Q57931616 | ||
Annexin A2 binds to the localization signal in the 3′ untranslated region of c-myc mRNA | Q58830802 | ||
Immunological profiles in workers of a power plant burning coal rich in arsenic content | Q69036583 | ||
Exposure to inorganic arsenic metabolites during early human development | Q77316942 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | arsenic | Q871 |
P1104 | number of pages | 8 | |
P304 | page(s) | 404-411 | |
P577 | publication date | 2006-03-01 | |
P1433 | published in | Environmental Health Perspectives | Q1345904 |
P1476 | title | Global gene expression associated with hepatocarcinogenesis in adult male mice induced by in utero arsenic exposure | |
P478 | volume | 114 |
Q36048210 | A distinct and replicable variant of the squamous cell carcinoma gene inositol polyphosphate-5-phosphatase modifies the susceptibility of arsenic-associated skin lesions in Bangladesh |
Q35952143 | A high concentration of genistein down-regulates activin A, Smad3 and other TGF-β pathway genes in human uterine leiomyoma cells |
Q38969931 | A time-series analysis of altered histone H3 acetylation and gene expression during the course of MMAIII-induced malignant transformation of urinary bladder cells |
Q36768351 | Aberrant DNA methylation and gene expression in livers of newborn mice transplacentally exposed to a hepatocarcinogenic dose of inorganic arsenic |
Q34727862 | Aberrantly Expressed Genes in HaCaT Keratinocytes Chronically Exposed to Arsenic Trioxide |
Q42562508 | Arsenic and Latent Disease Risk: What's the Mechanism of Action? |
Q28387404 | Arsenic and cardiovascular disease |
Q28383459 | Arsenic as an endocrine disruptor: arsenic disrupts retinoic acid receptor-and thyroid hormone receptor-mediated gene regulation and thyroid hormone-mediated amphibian tail metamorphosis |
Q34002291 | Arsenic as an endocrine disruptor: effects of arsenic on estrogen receptor-mediated gene expression in vivo and in cell culture |
Q37231348 | Arsenic-induced aberrant gene expression in fetal mouse primary liver-cell cultures |
Q35879729 | Blood metallothionein transcript as a biomarker for metal sensitivity: low blood metallothionein transcripts in arsenicosis patients from Guizhou, China |
Q42912937 | Carbon tetrachloride affects inflammation-related biochemical networks in the mouse liver as identified by a customized cDNA microarray system |
Q43295840 | Fetal arsenic exposure appears to facilitate endocrine disruption by postnatal diethylstilbestrol in neonatal mouse adrenal |
Q28389068 | Fetal onset of aberrant gene expression relevant to pulmonary carcinogenesis in lung adenocarcinoma development induced by in utero arsenic exposure |
Q33286948 | Global gene expression profiling in human lung cells exposed to cobalt |
Q38495569 | Hepatic gene expression analysis of mice exposed to raw water from Meiliang Bay, Lake Taihu, China |
Q46736290 | High dietary fat exacerbates arsenic-induced liver fibrosis in mice |
Q28395561 | Hormesis and its place in nonmonotonic dose-response relationships: some scientific reality checks |
Q57929665 | Impact of prenatal arsenic exposure on chronic adult diseases |
Q28388283 | In utero and postnatal exposure to arsenic alters pulmonary structure and function |
Q28396050 | Inorganic arsenic as a developmental toxicant: in utero exposure and alterations in the developing rat lungs |
Q47159846 | Integration of microRNAome, proteomics and metabolomics to analyze arsenic-induced malignant cell transformation |
Q28390690 | Liver is a target of arsenic carcinogenesis |
Q33725591 | Long-term health consequences of prenatal arsenic exposure: links to the genome and the epigenome |
Q57434113 | Major histopathological patterns of lung cancer related to arsenic exposure in German uranium miners |
Q30431758 | Mechanistic exploration of phthalimide neovascular factor 1 using network analysis tools |
Q37080710 | Microarray and pathway analysis reveals decreased CDC25A and increased CDC42 associated with slow growth of BCL2 overexpressing immortalized breast cell line |
Q35044706 | Moving forward in human cancer risk assessment |
Q33686507 | Nrf2-dependent sulfiredoxin-1 expression protects against cigarette smoke-induced oxidative stress in lungs |
Q33621764 | Prenatal arsenic exposure and the epigenome: altered microRNAs associated with innate and adaptive immune signaling in newborn cord blood. |
Q34760242 | Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes |
Q34556822 | Proteomics-Based Identification of Differentially Abundant Proteins from Human Keratinocytes Exposed to Arsenic Trioxide |
Q35633882 | Toxicogenomic biomarkers for liver toxicity |
Q43263160 | Transcriptional changes associated with reduced spontaneous liver tumor incidence in mice chronically exposed to high dose arsenic |
Q28396711 | Transplacental arsenic carcinogenesis in mice |
Q37187687 | Transplacental exposure to inorganic arsenic at a hepatocarcinogenic dose induces fetal gene expression changes in mice indicative of aberrant estrogen signaling and disrupted steroid metabolism |
Search more.